Expect Wall Street to pay close attention to how healthcare information system company Eclipsys performs over the quarter to come. Yesterday, the company announced its third-quarter revenue was $97.9 million, an increase of 23 percent over last year. This week Eclipsys named Andrew Eckert CEO, solidifying its management team. With shares priced at around $16, the company is seen as a bargain by some analysts, who feel the company is poised to overcome some problems with a technology transition and compete with the bigger names in the sector. Release